Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study

Rahbar, Kambiz; Essler, Markus; Pabst, Kim M.; Eiber, Matthias; la Fouge, Christian; Prasad, Vikas; Rassek, Philipp; Hasa, Ergela; Dittmann, Helmut; Bundschuh, Ralph A.; Fendler, Wolfgang P.; Kurtinecz, Milena; Schmall, Anja; Verholen, Frank; Sartor, Oliver

dc.contributor.author	Dittmann, Helmut
dc.contributor.author	La Fougère, Christian Jean
dc.date.accessioned	2024-05-14T06:56:27Z
dc.date.available	2024-05-14T06:56:27Z
dc.date.issued	2023
dc.identifier.issn	0161-5505
dc.identifier.uri	http://hdl.handle.net/10900/153329
dc.language.iso	en	de_DE
dc.publisher	Reston : Soc Nuclear Medicine Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.2967/jnumed.122.264456	de_DE
dc.subject.ddc	610	de_DE
dc.title	Safety and Survival Outcomes of 177Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with Prior 223Ra treatment: The RALU Study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_01833
utue.publikation.seiten	574-578	de_DE
utue.personen.roh	Rahbar, Kambiz
utue.personen.roh	Essler, Markus
utue.personen.roh	Pabst, Kim M.
utue.personen.roh	Eiber, Matthias
utue.personen.roh	la Fouge, Christian
utue.personen.roh	Prasad, Vikas
utue.personen.roh	Rassek, Philipp
utue.personen.roh	Hasa, Ergela
utue.personen.roh	Dittmann, Helmut
utue.personen.roh	Bundschuh, Ralph A.
utue.personen.roh	Fendler, Wolfgang P.
utue.personen.roh	Kurtinecz, Milena
utue.personen.roh	Schmall, Anja
utue.personen.roh	Verholen, Frank
utue.personen.roh	Sartor, Oliver
dcterms.isPartOf.ZSTitelID	Journal of Nuclear Medicine	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	64	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE